← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

IRTC logoiRhythm Technologies, Inc.(IRTC)Earnings, Financials & Key Ratios

IRTC•NASDAQ
$117.70
$3.87B mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryPatient monitoring and wearable diagnostics
AboutiRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Show more
  • Revenue$747M+26.2%
  • EBITDA-$10M+88.5%
  • Net Income-$45M+60.7%
  • EPS (Diluted)-1.39+61.7%
  • Gross Margin70.57%+2.5%
  • EBITDA Margin-1.38%+90.9%
  • Operating Margin-4.93%+74.8%
  • Net Margin-5.96%+68.8%
  • ROE-36.57%+51.4%
  • ROIC-5.23%+78.5%
  • Debt/Equity4.79-40.9%
  • Interest Coverage-2.80+64.1%
Technical→

IRTC Key Insights

iRhythm Technologies, Inc. (IRTC) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 23.0%

✗Weaknesses

  • ✗High debt to equity ratio of 4.8x
  • ✗Weak momentum: RS Rating 18 (bottom 18%)
  • ✗Trading more than 30% below 52-week high
  • ✗Expensive at 24.7x book value

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

IRTC Price & Volume

iRhythm Technologies, Inc. (IRTC) stock price & volume — 10-year historical chart

Loading chart...

IRTC Growth Metrics

iRhythm Technologies, Inc. (IRTC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years35.38%
5 Years23.02%
3 Years22.05%
TTM27.36%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM71.74%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM72.63%

Return on Capital

10 Years-24.96%
5 Years-23.28%
3 Years-20.35%
Last Year-4.36%

IRTC Recent Earnings

iRhythm Technologies, Inc. (IRTC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 10/12 qtrs (83%)
Q2 2026Latest
Apr 30, 2026
EPS
$0.43
Est $0.56
+23.2%
Revenue
$199M
Est $194M
+2.7%
Q1 2026
Feb 19, 2026
EPS
$0.17
Est $0.02
+750.0%
Revenue
$209M
Est $202M
+3.5%
Q4 2025
Oct 30, 2025
EPS
$0.06
Est $0.36
+83.3%
Revenue
$193M
Est $202M
-4.4%
Q3 2025
Jul 31, 2025
EPS
$0.32
Est $0.53
+39.6%
Revenue
$187M
Est $176M
+6.4%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 30, 2026
$0.43vs $0.56+23.2%
$199Mvs $194M+2.7%
Q1 2026Feb 19, 2026
$0.17vs $0.02+750.0%
$209Mvs $202M+3.5%
Q4 2025Oct 30, 2025
$0.06vs $0.36+83.3%
$193Mvs $202M-4.4%
Q3 2025Jul 31, 2025
$0.32vs $0.53+39.6%
$187Mvs $176M+6.4%
Based on last 12 quarters of dataView full earnings history →

IRTC Peer Comparison

iRhythm Technologies, Inc. (IRTC) competitors in Patient monitoring and wearable diagnostics — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
ITGR logoITGRInteger Holdings CorporationDirect Competitor2.97B86.2929.867.57%7.67%8.23%3.54%0.80
INVA logoINVAInnoviva, Inc.Direct Competitor1.68B22.526.8218.52%65.38%23.12%11.65%
BDX logoBDXBecton, Dickinson and CompanyDirect Competitor52.45B144.7624.838.23%8.01%6.93%5.09%0.76
HOLX logoHOLXHologic, Inc.Direct Competitor16.97B76.0130.531.74%13.18%10.37%5.42%0.52
NVCR logoNVCRNovoCure LimitedDirect Competitor1.88B16.50-13.528.28%-25.66%-50.82%0.85
MDT logoMDTMedtronic plcProduct Competitor99.48B77.6021.503.62%13%9.45%5.21%0.59
ABT logoABTAbbott LaboratoriesProduct Competitor149.97B86.2511.294.59%31.88%27.26%4.23%0.32
BSX logoBSXBoston Scientific CorporationProduct Competitor83.23B56.0028.8719.87%14.4%12.4%4.4%0.51

Compare IRTC vs Peers

iRhythm Technologies, Inc. (IRTC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ITGR

Most directly comparable listed peer for IRTC.

Scale Benchmark

vs ABT

Larger-name benchmark to compare IRTC against a more recognizable public peer.

Peer Set

Compare Top 5

vs ITGR, INVA, BDX, HOLX

IRTC Income Statement

iRhythm Technologies, Inc. (IRTC) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue99.13M147.28M214.55M265.17M322.82M410.92M492.68M591.84M747.14M787.85M
Revenue Growth %54.72%48.57%45.68%23.59%21.74%27.29%19.9%20.13%26.24%27.36%
Cost of Goods Sold28.2M38.8M52.48M70.28M109.26M129.29M160.88M184.31M219.89M228.46M
COGS % of Revenue28.45%26.34%24.46%26.5%33.84%31.46%32.65%31.14%29.43%-
Gross Profit
70.93M▲ 0%
108.48M▲ 53.0%
162.07M▲ 49.4%
194.89M▲ 20.3%
213.57M▲ 9.6%
281.63M▲ 31.9%
331.81M▲ 17.8%
407.53M▲ 22.8%
527.25M▲ 29.4%
559.39M▲ 0%
Gross Margin %71.55%73.66%75.54%73.5%66.16%68.54%67.35%68.86%70.57%71%
Gross Profit Growth %64.22%52.95%49.4%20.25%9.58%31.87%17.82%22.82%29.38%-
Operating Expenses98.52M154.17M216.82M238.56M313.51M395.42M456.97M523.04M564.06M585.04M
OpEx % of Revenue99.38%104.68%101.06%89.97%97.11%96.23%92.75%88.37%75.5%-
Selling, General & Admin85.25M133.31M179.52M197.23M274.84M322.2M385.64M418.56M479.45M500.59M
SG&A % of Revenue86%90.52%83.67%74.38%85.14%78.41%78.27%70.72%64.17%-
Research & Development13.27M20.86M37.3M41.33M38.67M46.61M60.24M103.83M84.61M84.45M
R&D % of Revenue13.38%14.16%17.38%15.59%11.98%11.34%12.23%17.54%11.32%-
Other Operating Expenses0000026.61M11.08M641K00
Operating Income
-27.59M▲ 0%
-45.69M▼ 65.6%
-54.76M▼ 19.8%
-43.67M▲ 20.2%
-99.94M▼ 128.8%
-113.78M▼ 13.8%
-125.16M▼ 10.0%
-115.5M▲ 7.7%
-36.81M▲ 68.1%
-25.95M▲ 0%
Operating Margin %-27.83%-31.02%-25.52%-16.47%-30.96%-27.69%-25.4%-19.52%-4.93%-3.29%
Operating Income Growth %-77.07%-65.6%-19.84%20.24%-128.84%-13.85%-10%7.71%68.13%-
EBITDA-25.99M-43.42M-51.31M-30.74M-83.35M-94.17M-103.02M-89.73M-10.33M-6.08M
EBITDA Margin %-26.22%-29.48%-23.91%-11.59%-25.82%-22.92%-20.91%-15.16%-1.38%-0.77%
EBITDA Growth %-73.13%-67.05%-18.17%40.08%-171.12%-12.99%-9.39%12.9%88.49%92.74%
D&A (Non-Cash Add-back)1.6M2.27M3.44M12.93M16.59M19.61M22.14M25.78M26.48M19.88M
EBIT-26.35M-47.22M-52.86M-42.08M-99.83M-111.75M-119.01M-99.9M-36.81M-9.77M
Net Interest Income-3.39M-3.12M-1.64M-1.52M-1.05M-1.79M2.5M9.12M8.37M6.72M
Interest Income0000118K2.35M6.16M21.94M21.52M21.48M
Interest Expense3.39M3.12M1.64M1.52M1.17M4.14M3.65M12.82M13.15M6.59M
Other Income/Expense-2.15M-4.64M252K72K-1.05M-2.1M2.5M2.78M-6.79M-1.04M
Pretax Income
-29.74M▲ 0%
-50.33M▼ 69.2%
-54.5M▼ 8.3%
-43.6M▲ 20.0%
-100.99M▼ 131.6%
-115.89M▼ 14.7%
-122.66M▼ 5.8%
-112.72M▲ 8.1%
-43.6M▲ 61.3%
-27M▲ 0%
Pretax Margin %-30%-34.18%-25.4%-16.44%-31.28%-28.2%-24.9%-19.05%-5.84%-3.43%
Income Tax044K65K229K367K269K750K565K953K788K
Effective Tax Rate %0%-0.09%-0.12%-0.53%-0.36%-0.23%-0.61%-0.5%-2.19%-2.92%
Net Income
-29.74M▲ 0%
-50.38M▼ 69.4%
-54.57M▼ 8.3%
-43.83M▲ 19.7%
-101.36M▼ 131.3%
-116.16M▼ 14.6%
-123.41M▼ 6.2%
-113.29M▲ 8.2%
-44.55M▲ 60.7%
-27.78M▲ 0%
Net Margin %-30%-34.21%-25.43%-16.53%-31.4%-28.27%-25.05%-19.14%-5.96%-3.53%
Net Income Growth %-42.28%-69.39%-8.32%19.68%-131.26%-14.6%-6.24%8.2%60.67%71.74%
Net Income (Continuing)-29.74M-50.38M-54.57M-43.83M-101.36M-116.16M-123.41M-113.29M-44.55M-27.78M
Discontinued Operations0000000000
Minority Interest0000000000
EPS (Diluted)
-1.30▲ 0%
-2.02▼ 55.4%
-2.16▼ 6.9%
-1.58▲ 26.9%
-3.46▼ 119.0%
-3.88▼ 12.1%
-4.04▼ 4.1%
-3.63▲ 10.1%
-1.39▲ 61.7%
-0.85▲ 0%
EPS Growth %67.09%-55.38%-6.93%26.85%-118.99%-12.14%-4.12%10.15%61.71%72.63%
EPS (Basic)-1.30-2.02-2.16-1.58-3.46-3.88-4.04-3.63-1.39-
Diluted Shares Outstanding22.63M23.89M25.27M27.75M29.33M29.92M30.53M31.2M32M32.51M
Basic Shares Outstanding22.63M23.89M25.27M27.75M29.33M29.92M30.53M31.2M32M32.51M
Dividend Payout Ratio----------

IRTC Balance Sheet

iRhythm Technologies, Inc. (IRTC) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets119.58M106.48M172.79M377.82M305.52M288.77M230.81M645.82M702.76M680.56M
Cash & Short-Term Investments102.36M78.34M140.55M335.22M239.13M213.14M133.76M535.55M583.76M549.62M
Cash Only8.67M20.02M20.46M88.63M127.56M78.83M36.17M419.6M236.01M240.15M
Short-Term Investments93.69M58.32M120.09M246.59M111.57M134.31M97.59M115.96M347.75M309.47M
Accounts Receivable12.95M19.79M23.87M29.93M46.43M49.92M61.48M79.94M75.71M80.86M
Days Sales Outstanding47.6949.0540.641.252.544.3445.5549.336.9836.47
Inventory1.68M2.06M4.04M5.31M10.27M15.15M13.97M14.04M21.63M23.8M
Days Inventory Outstanding21.7819.428.0727.5934.342.7831.727.835.9133.31
Other Current Assets2.58M4.1M4.34M7.36M9.69M10.55M21.59M16.29M21.66M26.27M
Total Non-Current Assets13.54M13.23M133.42M133.91M157.44M159.45M202.33M285.63M317.28M325.81M
Property, Plant & Equipment6.22M9.16M116.59M118.96M140.53M136.34M153.43M172.66M193.43M197.03M
Fixed Asset Turnover15.93x16.08x1.84x2.23x2.30x3.01x3.21x3.43x3.86x4.11x
Goodwill862K862K862K862K862K862K862K862K862K862K
Intangible Assets0000000000
Long-Term Investments2.99M08.03M0003M61.9M69.91M275.76M
Other Non-Current Assets3.46M3.21M7.94M14.09M16.05M22.25M45.04M50.21M53.08M211.65M
Total Assets
133.12M▲ 0%
119.71M▼ 10.1%
306.21M▲ 155.8%
511.74M▲ 67.1%
462.97M▼ 9.5%
448.22M▼ 3.2%
433.14M▼ 3.4%
931.45M▲ 115.0%
1.02B▲ 9.5%
1.01B▲ 0%
Asset Turnover0.74x1.23x0.70x0.52x0.70x0.92x1.14x0.64x0.73x0.79x
Asset Growth %-3.64%-10.08%155.79%67.12%-9.53%-3.18%-3.36%115.04%9.51%32.46%
Total Current Liabilities20.92M30.24M52.07M65.67M87.85M89.1M107.37M110.92M151.89M131.75M
Accounts Payable2.4M2.28M8.24M4.37M10.51M7.52M5.54M7.22M2.26M8.56M
Days Payables Outstanding3121.4957.3222.6735.1121.2212.5814.33.7412.73
Short-Term Debt1.49M01.94M11.67M11.67M00016.69M16.79M
Deferred Revenue (Current)1.24M1.24M1.25M930K3.05M3.05M3.31M2.93M4.2M15.98M
Other Current Liabilities1.38M5.81M9.75M13.96M8.57M18.7M1.04M35.11M128.75M102.34M
Current Ratio5.72x3.52x3.32x5.75x3.48x3.24x2.15x5.82x4.63x4.63x
Quick Ratio5.64x3.45x3.24x5.67x3.36x3.07x2.02x5.70x4.48x4.48x
Cash Conversion Cycle38.4846.9611.3546.1251.6965.964.6862.869.1557.05
Total Non-Current Liabilities32.65M35.05M118.74M104.46M95.6M119.31M115.68M729.62M715.41M713.4M
Long-Term Debt32.49M34.9M32.99M21.34M9.69M34.94M34.95M646.44M714.5M712.5M
Capital Lease Obligations0085.75M81.29M85.21M83.07M79.72M74.6M070.38M
Deferred Tax Liabilities0000000000
Other Non-Current Liabilities161K153K01.83M697K1.31M1.01M8.58M908K21.52M
Total Liabilities53.57M65.29M170.8M170.13M183.45M208.41M223.05M840.54M867.3M845.15M
Total Debt33.98M34.9M128.59M122.47M117.71M131.04M129.82M736.91M731.18M729.29M
Net Debt25.31M14.88M108.13M33.84M-9.85M52.21M93.65M317.31M495.17M489.14M
Debt / Equity0.43x0.64x0.95x0.36x0.42x0.55x0.62x8.11x4.79x4.79x
Debt / EBITDA----------120.05x
Net Debt / EBITDA----------80.52x
Interest Coverage-7.78x-15.16x-32.17x-27.70x-85.39x-27.01x-32.60x-7.79x-2.80x-1.48x
Total Equity
79.55M▲ 0%
54.42M▼ 31.6%
135.41M▲ 148.8%
341.61M▲ 152.3%
279.51M▼ 18.2%
239.81M▼ 14.2%
210.1M▼ 12.4%
90.91M▼ 56.7%
152.75M▲ 68.0%
161.21M▲ 0%
Equity Growth %-14.05%-31.59%148.81%152.28%-18.18%-14.2%-12.39%-56.73%68.02%228.39%
Book Value per Share3.522.285.3612.319.538.026.882.914.774.96
Total Shareholders' Equity79.55M54.42M135.41M341.61M279.51M239.81M210.1M90.91M152.75M161.21M
Common Stock23K23K25K27K27K28K31K31K32K33K
Retained Earnings-156.59M-203.51M-260.39M-304.68M-406.05M-522.2M-645.61M-758.89M-803.45M-817.38M
Treasury Stock0000000-25M00
Accumulated OCI-65K-41K82K11K-61K-396K-112K165K403K42K
Minority Interest0000000000

IRTC Cash Flow Statement

iRhythm Technologies, Inc. (IRTC) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations-14.91M-29.07M-21.86M-13.76M-37.75M-23.01M-50.1M3.39M80.86M80.86M
Operating CF Margin %-15.04%-19.74%-10.19%-5.19%-11.69%-5.6%-10.17%0.57%10.82%-
Operating CF Growth %10.45%-94.94%24.79%37.07%-174.39%39.05%-117.72%106.77%2285.34%-18.51%
Net Income-29.42M-48.28M-54.57M-43.83M-101.36M-116.16M-123.41M0-44.55M-27.78M
Depreciation & Amortization1.6M2.27M3.44M6.9M16.59M19.61M22.14M0022.11M
Stock-Based Compensation10.12M16.33M26.24M41.52M54.53M57.74M77.2M0065.32M
Deferred Taxes9.06M17.41M23.76M31.86M000000
Other Non-Cash Items1.81M-2.93M8.99M6.03M38.72M81.3M76M102.51M217.11M58.33M
Working Capital Changes-8.08M-13.87M-29.73M-56.23M-46.23M-65.51M-102.05M-99.12M-91.7M-55.4M
Change in Receivables-12.95M-22.89M-28.73M-37.96M-53.57M-61.84M-81.19M-91.92M-95.43M-98.31M
Change in Inventory-293K-380K-1.97M-1.39M-4.96M-5.11M979K-224K-8.51M-10.55M
Change in Payables634K-192K5.6M-3.88M6.13M-2.99M-1.97M-7.41M28.04M-9M
Cash from Investing-34.59M34.12M-89.27M-132.39M105.26M-52.43M-1.21M-122.98M-277.06M-208.7M
Capital Expenditures-3.56M-5.18M-20.46M-13.55M-28.07M-29.83M-40.42M-33.94M-46.34M-43.83M
CapEx % of Revenue3.59%3.52%9.53%5.11%8.69%7.26%8.2%5.73%6.2%-
Acquisitions0068.82M118.84M000000
Investments----------
Other Investing91K39.32M-68.82M-118.84M000-89.04M00
Cash from Financing6.53M6.3M111.58M214.32M-28.58M26.72M8.82M511.38M12.61M11.03M
Debt Issued (Net)03.5M0-1.94M-11.67M13.53M0619.84M00
Equity Issued (Net)6.39M0107.37M206.03M8.94M00-25M12.61M10.05M
Dividends Paid0000000000
Share Repurchases0-3.88M00000-25M00
Other Financing142K2.8M4.21M10.23M-25.85M13.18M8.82M-83.46M0974K
Net Change in Cash
-42.97M▲ 0%
11.35M▲ 126.4%
439K▼ 96.1%
68.17M▲ 15427.6%
38.93M▼ 42.9%
-48.73M▼ 225.2%
-42.66M▲ 12.5%
391.78M▲ 1018.4%
-183.59M▼ 146.9%
-135.13M▲ 0%
Free Cash Flow
-18.47M▲ 0%
-34.25M▼ 85.4%
-42.32M▼ 23.6%
-27.31M▲ 35.5%
-65.82M▼ 141.0%
-52.84M▲ 19.7%
-90.53M▼ 71.3%
-30.55M▲ 66.3%
34.52M▲ 213.0%
18.75M▲ 0%
FCF Margin %-18.64%-23.25%-19.72%-10.3%-20.39%-12.86%-18.37%-5.16%4.62%2.38%
FCF Growth %4.85%-85.39%-23.57%35.47%-141.01%19.72%-71.31%66.25%212.99%34.5%
FCF per Share-0.82-1.43-1.67-0.98-2.24-1.77-2.97-0.981.081.08
FCF Conversion (FCF/Net Income)0.50x0.58x0.40x0.31x0.37x0.20x0.41x-0.03x-1.82x-0.67x
Interest Paid000003.32M2.96M6.39M04.96M
Taxes Paid00000287K1.13M923K0546K

IRTC Key Ratios

iRhythm Technologies, Inc. (IRTC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)-34.56%-75.21%-57.49%-18.38%-32.64%-44.73%-54.86%-75.27%-36.57%-20.6%
Return on Invested Capital (ROIC)-23.25%-39.35%-26.25%-10.58%-23.24%-30.39%-31.51%-24.34%-5.23%-5.23%
Gross Margin71.55%73.66%75.54%73.5%66.16%68.54%67.35%68.86%70.57%71%
Net Margin-30%-34.21%-25.43%-16.53%-31.4%-28.27%-25.05%-19.14%-5.96%-3.53%
Debt / Equity0.43x0.64x0.95x0.36x0.42x0.55x0.62x8.11x4.79x4.79x
Interest Coverage-7.78x-15.16x-32.17x-27.70x-85.39x-27.01x-32.60x-7.79x-2.80x-1.48x
FCF Conversion0.50x0.58x0.40x0.31x0.37x0.20x0.41x-0.03x-1.82x-0.67x
Revenue Growth54.72%48.57%45.68%23.59%21.74%27.29%19.9%20.13%26.24%27.36%

IRTC SEC Filings & Documents

iRhythm Technologies, Inc. (IRTC) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 30, 2026·SEC

Material company update

Apr 1, 2026·SEC

Material company update

Mar 12, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 19, 2026·SEC

FY 2025

Feb 20, 2025·SEC

FY 2024

Feb 22, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Apr 30, 2026·SEC

FY 2025

Oct 30, 2025·SEC

FY 2025

Jul 31, 2025·SEC

IRTC Frequently Asked Questions

iRhythm Technologies, Inc. (IRTC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

iRhythm Technologies, Inc. (IRTC) reported $787.9M in revenue for fiscal year 2025. This represents a 5027% increase from $15.4M in 2013.

iRhythm Technologies, Inc. (IRTC) grew revenue by 26.2% over the past year. This is strong growth.

iRhythm Technologies, Inc. (IRTC) reported a net loss of $27.8M for fiscal year 2025.

Dividend & Returns

iRhythm Technologies, Inc. (IRTC) has a return on equity (ROE) of -36.6%. Negative ROE indicates the company is unprofitable.

iRhythm Technologies, Inc. (IRTC) generated $18.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More IRTC

iRhythm Technologies, Inc. (IRTC) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.